Nanoscience can offer solutions, not only problems, to environmental challenges, addressing pollution and enhancing ...

The bar for product differentiation and commercial viability has never been higher. Efficiency, external collaboration, and ...

Editor’s Note: This deep dive was originally published Sept. 24, 2025, as a special edition of Biopharm Executive. Subscribe ...

Expertise from Forbes Councils members, operated under license. Opinions expressed are those of the author. Every year, thousands of biotech breakthroughs stall. Not because the science failed, but ...

Depending on the setting, the ability of a crucial bacterium in biotechnology—Agrobacterium tumefaciens—to transfer its DNA ...

The goal of gene therapy is to permanently cure hereditary diseases. One of the most promising technologies for this is the ...

In this market, three things make fundraising easier for a biotech: a derisked asset touting a well-defined profile and an experienced team to guide the program’s development. Crystalys Therapeutics ...

For decades, biotechnology was among the few areas of collaboration between China and the United States, and the partnership delivered significant gains on both sides. China sought to raise its ...

Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Mirador Therapeutics has raised $400mn in one of the largest biotech deals this year, increasing hopes of ...

Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. MAIA Biotechnology, Inc. ( (MAIA)) has ...

The past decade has witnessed remarkable advances in computational power, algorithms, and theoretical methods, enabling accurate modeling and prediction of ...